A New Jersey man who was diagnosed with Parkinson’s disease in 2022 is speaking about how a new FDA approved medication has helped improve his daily life. Gasper Giordano was diagnosed just three years ago and soon began to experience many of the challenges that are common among Parkinson’s patients. He found himself struggling with balance, having trouble holding even simple objects like a glass, and facing difficulty writing his own name. His movements became shaky, his steps unsteady, and his perception issues made walking even more difficult. These are the types of challenges that affect many people living with Parkinson’s disease and they often result in a major reduction of independence and quality of life.
Fortunately for Giordano, his daughter is a movement disorder specialist who works with patients suffering from Parkinson’s disease and other neurological conditions. She has spent years helping people manage their symptoms through medication, therapy, and lifestyle interventions. She is also a spokesperson for Crexont, a recently approved extended release capsule medication that was cleared by the Food and Drug Administration last year. Crexont works by helping the brain receive dopamine, a vital chemical that Parkinson’s patients lose as the disease progresses. The medication is designed to provide a steady release that helps reduce motor symptoms and can improve functionality throughout the day.
After beginning treatment with Crexont, Giordano quickly noticed improvements in his life that he had not expected. He described how he had often felt overwhelming fatigue before starting the new medication, saying he was always tired and drained of energy. However, after taking the extended release capsules, he felt more energetic, freer, and more capable of doing everyday tasks without constant struggle. He shared how his walking improved, his ability to think and use his brain felt sharper, and overall his daily living became easier. He admitted that he was surprised at how well the drug worked, but the results gave him a sense of hope and normalcy that had been missing since his diagnosis.
While Giordano’s positive experience highlights the impact that new medications can have on Parkinson’s patients, his daughter emphasizes that drug treatment alone is not the only path toward better health outcomes. She strongly encourages Parkinson’s patients to engage in physical activity and therapies that support movement and coordination. Activities such as physical therapy sessions, targeted exercise routines, and specialized programs like rock steady boxing can help patients maintain functionality, mobility, and independence. According to her, keeping the body moving is essential in slowing down the progression of symptoms and in maintaining muscle strength and coordination.
Parkinson’s disease is a progressive neurological disorder that affects millions of people worldwide. It develops when nerve cells in the brain that produce dopamine begin to break down, leading to motor symptoms such as tremors, stiffness, and balance problems, as well as non-motor issues including fatigue, cognitive decline, and mood disturbances. For many patients, finding the right treatment approach is a journey that requires a combination of medication, therapy, and lifestyle changes. The introduction of new FDA approved options like Crexont offers an added layer of hope, as it gives patients more tools to help manage their symptoms and maintain a higher quality of life.
Stories like Giordano’s demonstrate how advancements in medical treatments can directly change lives. While Parkinson’s disease remains incurable, the development of medications that improve daily functioning provides encouragement not only to patients but also to families and caregivers who walk alongside them in the journey. The balance of modern medicine and active lifestyle support shows the potential for patients to live fuller, more independent lives despite the challenges of the condition.
As research continues, more treatments are expected to emerge, giving patients greater choices in how they manage their symptoms. For now, the success stories from patients like Giordano offer proof that innovation in neurology can make a real difference. His experience illustrates the importance of access to new medications and the role of comprehensive care that combines medical and therapeutic approaches. The collaboration between scientific development, patient care, and supportive family involvement underscores the ongoing fight against Parkinson’s disease and the hope for a better future for those living with it.
